HL7 Terminology (THO)
7.4.0 - Publication
This page is part of the HL7 Terminology (v7.4.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://terminology.hl7.org/NamingSystem/HL7-AU-medication-type | Version: 1.0.0 | ||||
| Active as of 2026-06-19 | Responsible: HL7 Australia | Computable Name: HL7AUMedicationType | |||
Copyright/Legal: HL7 Australia Intellectual Property Policy: http://hl7.com.au/wp-content/uploads/2024/04/HL7A_IP_Policy_v1.00a_20240429_as_delivered.pdf |
|||||
The Medication Type code system defines concepts in a classification scheme for medication coding. The classification scheme defines the nature of the properties defined by the code e.g. branded product with no strength or form. This allows the distinction between codes provided containing container, pack, strength and form explicitly especially where terminologies supplied are unknown or terminology services are unavailable.
Language: en
| Defining URL | http://terminology.hl7.org/NamingSystem/HL7-AU-medication-type |
| Version | 1.0.0 |
| Name | HL7AUMedicationType |
| Title | Medication Type |
| Status | active |
| Definition | The Medication Type code system defines concepts in a classification scheme for medication coding. The classification scheme defines the nature of the properties defined by the code e.g. branded product with no strength or form. This allows the distinction between codes provided containing container, pack, strength and form explicitly especially where terminologies supplied are unknown or terminology services are unavailable. |
| Publisher | HL7 Australia |
| Copyright | HL7 Australia Intellectual Property Policy: http://hl7.com.au/wp-content/uploads/2024/04/HL7A_IP_Policy_v1.00a_20240429_as_delivered.pdf |
| Type | Value | Preferred |
| OID | 2.16.840.1.113883.2.3.4.1.4.1 | true |
| URI | http://terminology.hl7.org.au/CodeSystem/medication-type | true |